Egypt's Health Ministry on Thursday approved a new oral interferon-free hepatitis C drug, to be available at the national hepatitis treatment centers in the coming period.
In a statement on Thursday, AbbVie, the drug's manufacturer, said that "QUREVO" drug could yield 100% cure rate.
QUREVO is the first HCV infection treatment that has successfully demonstrated favorable safety and efficacy profiles, without necessitating co-administration with interferon.
The ministry gives high priority to the prevention and treatment of hepatitis.
According to the United Nations Population Fund, Egypt has the highest rate of hepatitis C infection in the world; 14.7 percent of the population between ages 15-49 have tested positive for the virus.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delaysMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor